JP2017537928A5 - - Google Patents

Download PDF

Info

Publication number
JP2017537928A5
JP2017537928A5 JP2017529817A JP2017529817A JP2017537928A5 JP 2017537928 A5 JP2017537928 A5 JP 2017537928A5 JP 2017529817 A JP2017529817 A JP 2017529817A JP 2017529817 A JP2017529817 A JP 2017529817A JP 2017537928 A5 JP2017537928 A5 JP 2017537928A5
Authority
JP
Japan
Prior art keywords
syringe
nominal volume
range
nominal
volume
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017529817A
Other languages
English (en)
Japanese (ja)
Other versions
JP6726666B2 (ja
JP2017537928A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2015/078482 external-priority patent/WO2016087569A1/en
Publication of JP2017537928A publication Critical patent/JP2017537928A/ja
Publication of JP2017537928A5 publication Critical patent/JP2017537928A5/ja
Application granted granted Critical
Publication of JP6726666B2 publication Critical patent/JP6726666B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017529817A 2014-12-03 2015-12-03 免疫グロブリンを含む安定性が高められた医薬製品 Active JP6726666B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14196069.0 2014-12-03
EP14196069 2014-12-03
PCT/EP2015/078482 WO2016087569A1 (en) 2014-12-03 2015-12-03 Pharmaceutical product with increased stability comprising immunoglobulins

Publications (3)

Publication Number Publication Date
JP2017537928A JP2017537928A (ja) 2017-12-21
JP2017537928A5 true JP2017537928A5 (OSRAM) 2018-12-27
JP6726666B2 JP6726666B2 (ja) 2020-07-22

Family

ID=52002817

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017529817A Active JP6726666B2 (ja) 2014-12-03 2015-12-03 免疫グロブリンを含む安定性が高められた医薬製品

Country Status (15)

Country Link
US (2) US12144861B2 (OSRAM)
EP (3) EP3763384B1 (OSRAM)
JP (1) JP6726666B2 (OSRAM)
KR (1) KR102745501B1 (OSRAM)
CN (1) CN106999588A (OSRAM)
AU (1) AU2015357068B2 (OSRAM)
BR (1) BR112017010442A2 (OSRAM)
CA (1) CA2968915A1 (OSRAM)
DK (2) DK3226895T3 (OSRAM)
ES (2) ES2825704T3 (OSRAM)
HU (2) HUE052280T2 (OSRAM)
MX (1) MX388043B (OSRAM)
PL (2) PL3763384T3 (OSRAM)
RU (1) RU2748841C2 (OSRAM)
WO (1) WO2016087569A1 (OSRAM)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011212440B2 (en) 2010-02-04 2015-01-22 Csl Behring Ag Immunoglobulin preparation
EP2361636A1 (en) * 2010-02-26 2011-08-31 CSL Behring AG Immunoglobulin preparation and storage system for an immunoglobulin preparation
MA54716A (fr) 2014-10-23 2021-11-17 Amgen Inc Réduction de la viscosité de formulations pharmaceutiques
CA2968915A1 (en) 2014-12-03 2016-06-09 Csl Behring Ag Pharmaceutical product with increased stability comprising immunoglobulins
JP7377596B2 (ja) * 2017-02-22 2023-11-10 アムジエン・インコーポレーテツド 低粘度、高濃度エボロクマブ製剤及びそれらの製造方法
TW202348250A (zh) * 2017-07-24 2023-12-16 美商再生元醫藥公司 穩定化之抗體組合物及其製法
AU2019274649B2 (en) * 2018-05-23 2025-10-09 Csl Behring Ag Treatment of CIDP
US12472162B2 (en) * 2018-07-24 2025-11-18 Carefusion 213, Llc Ready-to-use, terminally sterile packaging for surgical antiseptic and method of use
EP3659594B1 (de) * 2018-11-30 2020-11-18 Klaus Stegemann Eine sterile lösung mit einem medizinischen wirkstoff enthaltende applikationsspritze und verfahren für deren bereitstellung
TW202535483A (zh) 2019-07-29 2025-09-16 美商里珍納龍藥品有限公司 醫療器材封裝及相關之方法
WO2022216985A1 (en) * 2021-04-08 2022-10-13 Genixus, Corp. Syringe prefilled with pharmaceutical fluid
US20250320279A1 (en) * 2021-11-30 2025-10-16 Sab, Llc Ungulate-derived polyclonal immunoglobulin specific for influenza virus and uses thereof
USD1042107S1 (en) 2022-08-26 2024-09-17 Regeneron Pharmaceuticals, Inc. Packaging
USD1035436S1 (en) 2022-08-26 2024-07-16 Regeneron Pharmaceuticals, Inc. Packaging
USD1047700S1 (en) 2022-08-26 2024-10-22 Regeneron Pharmaceuticals, Inc. Packaging
WO2024200757A1 (en) 2023-03-29 2024-10-03 Csl Behring Ag Methods of identifying immunoglobulin associated with adverse reactions

Family Cites Families (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2364792A1 (de) 1973-01-15 1974-07-18 South African Inventions Verfahren zum reinigen von gammaglobulin
JPS5420124A (en) 1977-07-14 1979-02-15 Green Cross Corp:The Preparation of gamma-globulin intravenous injection
US4186192A (en) 1978-12-18 1980-01-29 Cutter Laboratories, Inc. Stabilized immune serum globulin
US4362661A (en) 1979-08-09 1982-12-07 Teijin Limited Immunoglobulin composition having a high monomer content, and process for production thereof
JPS5731623A (en) 1980-07-30 1982-02-20 Morishita Seiyaku Kk Production of gamma-globulin for intravenous injection
JPS56127321A (en) 1980-03-10 1981-10-06 Mochida Pharmaceut Co Ltd Preparation of gamma-globulin pharmaceutical
JPS56135418A (en) 1980-03-27 1981-10-22 Green Cross Corp:The Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
JPS57128635A (en) 1981-01-30 1982-08-10 Morishita Seiyaku Kk Pharmaceutical preparation of gamma-globulin for venoclysis
US4360451A (en) 1981-08-10 1982-11-23 Basf Wyandotte Corporation Amphoteric surfactant gels
US4499073A (en) 1981-08-24 1985-02-12 Cutter Laboratories, Inc. Intravenously injectable immune serum globulin
US4396608A (en) 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
US4439421A (en) 1982-08-30 1984-03-27 Baxter Travenol Laboratories, Inc. Stabilized gamma globulin concentrate
JPS6042336A (ja) 1983-08-18 1985-03-06 Nippon Seiyaku Kk 免疫グロブリンの製造方法
JPS60120823A (ja) 1983-12-02 1985-06-28 Green Cross Corp:The IgG単量体
US4597966A (en) 1985-01-09 1986-07-01 Ortho Diagnostic Systems, Inc. Histidine stabilized immunoglobulin and method of preparation
JPH0825902B2 (ja) 1985-02-21 1996-03-13 株式会社ミドリ十字 γ−グロブリンの加熱処理方法
JPH0825903B2 (ja) 1985-05-16 1996-03-13 株式会社ミドリ十字 γ―グロブリン含有水溶液
GB8628104D0 (en) 1986-11-25 1986-12-31 Connaught Lab Pasteurization of immunoglobin solutions
DE3641115A1 (de) 1986-12-02 1988-06-16 Lentia Gmbh Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins
JPH02290822A (ja) 1989-04-04 1990-11-30 Eli Lilly & Co 医薬製剤
JPH0341033A (ja) 1989-07-07 1991-02-21 Kyowa Hakko Kogyo Co Ltd 安定なモチリン類含有製剤
US5945098A (en) 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
US5177194A (en) 1990-02-01 1993-01-05 Baxter International, Inc. Process for purifying immune serum globulins
ES2074490T5 (es) 1990-03-22 2004-02-16 Biotest Pharma Gmbh Procedimiento para la elaboracion de un preparado de inmunoglobulina g tolerable por via intravenosa.
JPH04346934A (ja) 1991-05-24 1992-12-02 Green Cross Corp:The γ−グロブリンの液状製剤
DE4118912C1 (OSRAM) 1991-06-08 1992-07-02 Biotest Pharma Gmbh, 6072 Dreieich, De
DE4126983A1 (de) 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke
JP2942412B2 (ja) 1991-12-26 1999-08-30 鐘紡株式会社 化粧料
FR2706466B1 (fr) 1993-06-14 1995-08-25 Aetsrn Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré.
ATE175979T1 (de) 1993-12-27 1999-02-15 Rotkreuzstiftung Zentrallab Verfahren zur herstellung eines konzentrates von anti-d-immunoglobulin g und pharmazeutische zusammensetzung, die dieses enthält
JPH07238036A (ja) 1994-02-28 1995-09-12 Green Cross Corp:The 静注用グロブリン液状組成物のグロブリン二量体増加抑制方法
GB9418092D0 (en) 1994-09-08 1994-10-26 Red Cross Found Cent Lab Blood Organic compounds
JP3765108B2 (ja) 1994-09-30 2006-04-12 三菱ウェルファーマ株式会社 静脈注射用グロブリン製剤
JPH10509948A (ja) 1994-11-16 1998-09-29 バクスター インターナショナル インコーポレイテッド T細胞受容体ペプチドに対するヒト抗体およびそれらの調製方法
GB9610992D0 (en) 1996-05-24 1996-07-31 Glaxo Group Ltd Concentrated antibody preparation
TW491855B (en) 1996-08-07 2002-06-21 Csl Ltd Purification of immunoglobulins
EP0852951A1 (de) 1996-11-19 1998-07-15 Roche Diagnostics GmbH Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
TR199901968T2 (xx) 1996-12-24 1999-12-21 Biogen, Inc. Sabit s�v� interferon form�lleri.
US6171586B1 (en) 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
US5886154A (en) 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
PT911037E (pt) 1997-10-23 2002-12-31 Mitsubishi Pharma Corp Preparacao de imunoglobulina armazenavel a temperatura ambiente para injeccao intravenosa
US6162904A (en) 1997-12-24 2000-12-19 Alpha Therapeutic Corporation Manufacturing method for intraveneously administrable immune globulin and resultant product
PL196770B1 (pl) 1998-06-09 2008-01-31 Statens Seruminstitut Sposób oczyszczania immunoglobuliny, produkt immunoglobuliny i jego zastosowanie
SE0001128D0 (sv) 2000-03-30 2000-03-30 Amersham Pharm Biotech Ab A method of producing IgG
US6887462B2 (en) 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
GB0113179D0 (en) 2001-05-31 2001-07-25 Novartis Ag Organic compounds
AT410637B (de) * 2001-06-01 2003-06-25 Igeneon Krebs Immuntherapie Verwendung von polyklonalen immunglobulinen
CN1607968A (zh) * 2001-11-02 2005-04-20 梅里迪安医学技术公司 药物容器、用于施用药物的药物配送套件及其包装方法
JP2006502116A (ja) * 2002-07-12 2006-01-19 メダレックス, インク. タンパク質の酸化分解を防ぐ方法及び組成物
WO2004084816A2 (en) 2003-03-21 2004-10-07 Progenics Pharmaceuticals, Inc. IMPROVED CD4-IgG2 FORMULATIONS
US20050075611A1 (en) * 2003-10-01 2005-04-07 Hetzler Kevin G. Low extractable, thermoplastic syringe and tip cap
EP1532983A1 (en) 2003-11-18 2005-05-25 ZLB Bioplasma AG Immunoglobulin preparations having increased stability
US20060051347A1 (en) 2004-09-09 2006-03-09 Winter Charles M Process for concentration of antibodies and therapeutic products thereof
US20060076536A1 (en) * 2004-09-29 2006-04-13 Barshied Scott R Oxygen scavenging pharmaceutical package and methods for making same
EP1767347A1 (de) * 2005-09-27 2007-03-28 Alcan Technology & Management Ltd. Deckfolie für Blisterverpackungen
US8852167B2 (en) 2005-12-01 2014-10-07 Bayer Medical Care Inc. Medical connector
KR20090060453A (ko) 2006-09-25 2009-06-12 메디뮨 엘엘씨 안정화된 항체 제제 및 그것의 용도
GB0619060D0 (en) 2006-09-27 2006-11-08 Glaxosmithkline Biolog Sa Novel process
MX2010008696A (es) * 2008-02-07 2010-08-30 Amgen Inc Composiciones de proteina estabilizadas.
GB2471726B (en) * 2009-07-10 2013-09-11 Oval Medical Technologies Ltd A pre-filled syringe including an oxygen absorber
US9084743B2 (en) 2009-09-17 2015-07-21 Baxter International Inc. Stable co-formulation of hyaluronidase and immunoglobulin, and methods of use thereof
IN2012DN06720A (OSRAM) 2010-01-15 2015-10-23 Kirin Amgen Inc
AU2011212440B2 (en) 2010-02-04 2015-01-22 Csl Behring Ag Immunoglobulin preparation
EP2361636A1 (en) * 2010-02-26 2011-08-31 CSL Behring AG Immunoglobulin preparation and storage system for an immunoglobulin preparation
WO2012022734A2 (en) 2010-08-16 2012-02-23 Medimmune Limited Anti-icam-1 antibodies and methods of use
KR101875155B1 (ko) 2011-05-02 2018-07-09 밀레니엄 파머슈티컬스 인코퍼레이티드 항-α4β7 항체에 대한 제형
FR2995213A1 (fr) * 2012-09-12 2014-03-14 Lfb Biotechnologies Seringue contenant une composition, notamment pharmaceutique, comprenant des immunoglobulines, son procede de fabrication et son utilisation
PT2968729T (pt) 2013-03-14 2018-11-06 Fresenius Kabi Deutschland Gmbh Sistema de acondicionamento para fármacos sensíveis ao oxigénio
WO2014140095A1 (en) * 2013-03-14 2014-09-18 Becton Dickinson France S.A.S. Injectable morphine formulations
AU2015326037A1 (en) * 2014-10-02 2017-04-13 Terumo Kabushiki Kaisha Medical container for accommodating protein solution preparation therein
CA2968915A1 (en) 2014-12-03 2016-06-09 Csl Behring Ag Pharmaceutical product with increased stability comprising immunoglobulins

Similar Documents

Publication Publication Date Title
JP2017537928A5 (OSRAM)
JP2015503422A5 (OSRAM)
JP2016028092A5 (OSRAM)
JP2016065085A5 (OSRAM)
JP2015053053A5 (OSRAM)
EA201790630A1 (ru) Способы получения рибозидов
WO2015153889A3 (en) Materials and methods for the treatment of latent viral infection
MA41265A (fr) Compositions pour administration de médicaments iléo-jéjunal.
WO2016011222A3 (en) Circular polynucleotides
JP2016502162A5 (OSRAM)
JP2014237817A5 (OSRAM)
JP2016027901A5 (OSRAM)
IL247111A0 (en) Preventive or therapeutic agent for kidney disease
TWD173737S (zh) 肌肉鍛鍊機器
JP2018533683A5 (OSRAM)
JP2015186128A5 (OSRAM)
JP2016540026A5 (OSRAM)
JP2015173751A5 (OSRAM)
JP2016540019A5 (OSRAM)
WO2015138532A3 (en) Methods for the treatment of kidney fibrosis
JP2016038993A5 (OSRAM)
JP2015016294A5 (OSRAM)
UY4430S (es) “motocicleta”.
IL257940A (en) Vaccine compositions comprising c-c motif chemokine 22 (ccl22) or fragments thereof
JP2016053220A5 (OSRAM)